Biomedical Engineering Reference
In-Depth Information
interest of many researchers. Based on the organisation of lipids and drugs in the
particles, a wide variety of structural models have been described for SLNs and
NLCs. The drug release from lipid nanoparticles is a compromise between the
composition and the structural model obtained for each formulation.
References
Blasi P, Schoubben A, Romano G, Giovagnoli S, Di Michele A, Ricci M (2013a) Lipid nanopar-
ticles for brain targeting II. Technological characterization. Colloid Surf B 110:130-137
Blasi P, Schoubben A, Traina G, Manfroni G, Barberini L, Alberti P et al (2013b) Lipid nan-
oparticles for brain targeting III. Long-term stability and in vivo toxicity. Int J Pharm
454(1):316-323
Bummer P (2004) Physical chemical considerations of lipid-based oral drug delivery—solid lipid
nanoparticles. Crit Rev Ther Drug 21(1):19
Cavalli R, Bargoni A, Podio V, Muntoni E, Zara G, Gasco M (2003) Duodenal administration
of solid lipid nanoparticles loaded with different percentages of tobramycin. J Pharm Sci
92(5):1085-1094
Cavalli R, Gasco M, Chetoni P, Burgalassi S, Saettone M (2002) Solid lipid nanoparticles (SLN)
as ocular delivery system for tobramycin. Int J Pharm 238(1-2):241-245
Cavalli R, Morel S, Gasco M, Chetoni P (1995) Preparation and evaluation in vitro of colloidal
lipospheres containing pilocarpine as ion pair. Int J Pharm 117(2):243-246
Chapman D (1962) The polymorphism of glycerides. Chem Rev 62(5):433-456
Corrigan O, Healy A (2006) Surfactants in pharmaceutical products and systems. In: Swarbrick J
(ed) Encyclopedia of pharmaceutical technology, 3rd edn. Informa Healthcare, NY, USA, pp
3583-3596
Doktorovova S, Shegokar R, Fernandes L, Martins-Lopes P, Silva A, Müller R et al (2014)
Trehalose is not a universal solution for solid lipid nanoparticles freeze-drying. Pharm Dev
Technol 19(8):922-929
Durán-Lobato M, Enguix-González A, Fernández-Arévalo M, Martín-Banderas L (2013)
Statistical analysis of solid lipid nanoparticles produced by high-pressure homogenization: a
practical prediction approach. J Nanopart Res 15(2):1-14
Dwivedi P, Khatik R, Khandelwal K, Shukla R, Paliwal S, Dwivedi A et al (2014) Preparation
and characterization of solid lipid nanoparticles of antimalarial drug Arteether for oral
administration. J Biomater Tissue Eng 4(2):133-137
Finke J, Schur J, Richter C, Gothsch T, Kwade A, Büttgenbach S et al (2012) The influence of
customized geometries and process parameters on nanoemulsion and solid lipid nanoparticle
production in microsystems. Chem Eng J 209:126-137
Fundarò A, Cavalli R, Bargoni A, Vighetto D, Zara G, Gasco M (2000) Non-stealth and stealth
solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribu-
tion after i.v. administration to rats. Pharmacol Res 42(4):337-343
Jenning V, Gohla S (2000) Comparison of wax and glyceride solid lipid nanoparticles (SLN®).
Int J Pharm 196(2):219-222
Jenning V, Gysler A, Schäfer-Korting M, Gohla S (2000a) Vitamin A loaded solid lipid nanopar-
ticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm
Biopharm 49(3):211-218
Jenning V, Mäder K, Gohla S (2000b) Solid lipid nanoparticles (SLN™) based on binary mix-
tures of liquid and solid lipids: a 1H-NMR study. Int J Pharm 205(1-2):15-21
Jenning V, Schäfer-Korting M, Gohla S (2000c) Vitamin A-loaded solid lipid nanoparticles for
topical use: drug release properties. J Control Release 66(2-3):115-126
Search WWH ::
Custom Search